Bhavesh Kevadiya to Humans
This is a "connection" page, showing publications Bhavesh Kevadiya has written about Humans.
Connection Strength
0.050
-
Diagnostics for SARS-CoV-2 infections. Nat Mater. 2021 05; 20(5):593-605.
Score: 0.007
-
A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention. J Neuroimmune Pharmacol. 2021 06; 16(2):270-288.
Score: 0.007
-
Nanocarrier vaccines for SARS-CoV-2. Adv Drug Deliv Rev. 2021 04; 171:215-239.
Score: 0.007
-
Pharmacotherapeutics of SARS-CoV-2 Infections. J Neuroimmune Pharmacol. 2021 03; 16(1):12-37.
Score: 0.007
-
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections. J Neuroimmune Pharmacol. 2020 09; 15(3):359-386.
Score: 0.007
-
The Promise of Long-Acting Antiretroviral Therapies: From Need to Manufacture. Trends Microbiol. 2019 07; 27(7):593-606.
Score: 0.007
-
The Immunopathobiology of SARS-CoV-2 Infection. FEMS Microbiol Rev. 2021 11 23; 45(6).
Score: 0.002
-
Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review. J Neuroimmune Pharmacol. 2020 09; 15(3):350-358.
Score: 0.002
-
SARS-CoV-2 Infection Leads to Neurological Dysfunction. J Neuroimmune Pharmacol. 2020 06; 15(2):167-173.
Score: 0.002
-
Surface-engineered multimodal magnetic nanoparticles to manage CNS diseases. Drug Discov Today. 2019 03; 24(3):873-882.
Score: 0.002